[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335640-105":59,"doc-detail-335640-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-biomarkers-involved-in-the-progression-of-gallbladder-inflammatory-lesions-to-invasive-cancer-a-proteomic-approach","Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer - A proteomic approach","","The progression of gallbladder inflammatory lesions to invasive cancer remains insufficiently defined, driving the search for transition biomarkers. A label-free LC-MS/MS proteomic workflow profiled 10 cases each of gallbladder cancer and inflammatory lesions with technical duplicates. Protein markers were validated by ELISA in 80 samples (40 per group), supported by PPI and pathway bioinformatics, clinicopathological correlation testing, and prognostic assessment using Kaplan–Meier and Cox regression. RT-PCR further measured mRNA expression. Of 5714 proteins, 621 were differentially expressed, highlighting S100P, PIGR, C1QBP, TAGLN, and CNN1, and implicating proteoglycan and glycosaminoglycan metabolism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-biomarkers-involved-in-the-progression-of-gallbladder-inflammatory-lesions-to-invasive-cancer-a-proteomic-approach/335640/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-biomarkers-involved-in-the-progression-of-gallbladder-inflammatory-lesions-to-invasive-cancer-a-proteomic-approach/335640.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this study on gallbladder lesions and cancer?","Question",{"text":112,"@type":113},"The study aimed to identify and validate proteins associated with the progression of gallbladder inflammatory lesions to invasive cancer, supporting potential diagnostic biomarker development for gallbladder cancer (GBC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate protein biomarkers discovered and confirmed?",{"text":117,"@type":113},"Label-free LC-MS/MS proteomics was used for discovery, comparing GBC and inflammatory lesion samples. Validation was performed using ELISA in an independent set of 80 samples, with additional mRNA evaluation by RT-PCR.",{"name":119,"@type":110,"acceptedAnswer":120},"Which proteins were highlighted as significant biomarkers in the progression process?",{"text":121,"@type":113},"Five proteins showed significant differential expression: S100P, PIGR, and C1QBP were upregulated, while TAGLN and CNN1 were downregulated.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335640,1790095265,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","RESEARCH ARTICLE  \nMolecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer:  \nA proteomic approach  \nNeetu Rawal 1, Gururao Hariprasad 2, Sabyasachi Bandyopadhyay 3, Nihar Ranjan Dash 4, Sunil Kumar5, Prasenjit Das 6, Sharmistha Dey 2, Maroof Ahmad Khan 7, Amar Ranjan 1, Anita Chopra 1, Sundeep Saluja 8, Showket Hussain 9,  \nG. K. Rath10, Tanvir Kaur 11, and Pranay Tanwar 1 ∗  \nThe progression of gallbladder inflammatory lesions to invasive cancer remains poorly understood, necessitating research on biomarkers involved in this transition. This study aims to identify and validate proteins associated with this progression, offering insights into potential diagnostic biomarkers for gallbladder cancer (GBC). Label-free liquid chromatography-assisted tandem mass spectrometry (LC-MS/MS) proteomics was performed on samples from ten cases each of GBC and inflammatory lesions, with technical duplicates. Validation was conducted through the enzyme-linked immunosorbent assay (ELISA) using 80 samples (40 GBC and 40 inflammatory lesions). Bioinformatics tools analyzed protein–protein interaction (PPI) networks and pathways. Statistical correlations with clinicopathological variables were assessed. Prognostic evaluation utilized Kaplan–Meier survival analysis and Cox regression analyses. mRNA expressions were studied using real-time-polymerase chain reaction (RT-PCR). Out of 5714 proteins analyzed, 621 were differentially expressed. Three upregulated (the S100 calcium-binding protein P [S100P], polymeric immunoglobulin receptor [PIGR], and complement C1q-binding protein [C1QBP]) and two downregulated (transgelin [TAGLN] and calponin 1 [CNN1]) proteins showed significant expression. Pathway analysis implicated involvement of proteoglycans in cancer and glycosaminoglycan metabolism. Significant correlations were observed between protein concentrations and clinicopathological variables. Prognostic factors, such as tumor size, lymph node metastasis, and preoperative bilirubin levels were associated with overall survival (OS) . Protein-based assays demonstrated higher resolution compared to mRNA analysis, suggesting their utility in GBC risk stratification. S100P, PIGR, C1QBP, TAGLN, and CNN1 emerge as potential protein-based biomarkers involved in the progression from gallbladder inflammatory lesions to invasive cancer. These findings hold promise for improved diagnostic and prognostic strategies in GBC management.  \nKeywords: Liquid chromatography-assisted tandem mass spectrometry, biomarker, differentially expressed proteins, gallbladder cancer, ELISA, real time-polymerase chain reaction, inflammatory lesion.  \nIntroduction  \nGallbladder cancer (GBC) is a relatively rare but aggressive malignancy that accounts for approximately 165,000 (1.7%) cancer deaths annually worldwide [1, 2]. The greatest incidence rates of GBC are found in Chile (27 per 100,000 people), followed by northern India at 21.5 per 100,000 people. In India, GBC occurrence is signiﬁcantly higher in the northern regions compared to the southern states, with rates of 8.9 per 100,000 in Delhi compared to 0.8 per 100,000 in Chennai [3, 4]. The gallbladder is a small cystic organ located under the inferior surface of the liver. Its primary function is to store and concentrate bile  \nproduced by the liver and transport it to the small intestine via the cystic duct [1] . The gallbladder consists of several layers:(a) the mucosa (innermost layer of epithelial cells),(b) the muscular layer (smooth muscle cells), (c) the perimuscular layer (connective tissue), and (d) the serosa (outer layer) . Under the inﬂuence of gallstones and other carcinogenic insults, the normal gallbladder epithelial layer undergoes metaplastic changes, which can lead to dysplasia, carcinoma in situ (CIS), and eventually invasive carcinoma. The multistage pathogenesis of gallbladder carcinoma arises due to prolonged exposure to gallstones (cholelithiasis), creatin","cbCaicBzhXL5QbLL","https://ap.wps.com/l/cbCaicBzhXL5QbLL","pdf",5304170,29,"English","# Introduction\n## Study aims and rationale\n## Proteomic discovery and validation strategy\n## Differentially expressed proteins and biomarker candidates\n## Bioinformatics pathways and protein–protein interactions\n## Clinicopathological and prognostic correlations\n## mRNA validation via RT-PCR","[{\"question\":\"What was the purpose of this study on gallbladder lesions and cancer?\",\"answer\":\"The study aimed to identify and validate proteins associated with the progression of gallbladder inflammatory lesions to invasive cancer, supporting potential diagnostic biomarker development for gallbladder cancer (GBC).\"},{\"question\":\"How were candidate protein biomarkers discovered and confirmed?\",\"answer\":\"Label-free LC-MS/MS proteomics was used for discovery, comparing GBC and inflammatory lesion samples. Validation was performed using ELISA in an independent set of 80 samples, with additional mRNA evaluation by RT-PCR.\"},{\"question\":\"Which proteins were highlighted as significant biomarkers in the progression process?\",\"answer\":\"Five proteins showed significant differential expression: S100P, PIGR, and C1QBP were upregulated, while TAGLN and CNN1 were downregulated.\"}]","Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer - A proteomic approach | PDF",1790011774,73]